MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Neuroprotective Role of Diosgenin-Loaded Lipid Nanoparticles for Parkinson’s Disease: Pharmacokinetic and Pharmacodynamic Insights

    R. Rajput, S. Verma (Agra, India)

    Objective: To develop, optimize, and evaluate diosgenin-loaded solid lipid nanoparticles (DG-SLNs) and nanostructured lipid carriers (DG-NLCs) incorporated into hydrogel formulations (DG-SLN-C and DG-NLC-C) for improved…
  • 2025 International Congress

    Gait Assessment for Parkinson’s Disease Patients Utilizing a Pressure Sensor Insole System

    G. Karamanis, I. Boura, V. Skaramagkas, C. Chatzaki, I. Kyprakis, D. Fotiadis, M. Tsiknakis, C. Spanaki, Z. Kefalopoulou (Rion, Patras, Greece)

    Objective: This study is an extension of a pilot study performed in 2021 and aims to investigate the clinical significance of exploiting wearable sensors such…
  • 2025 International Congress

    AI-Driven Wearable Sensor Monitoring for Improved Assessment of Advanced Treatment Readiness in Parkinson’s Disease – A pilot study

    N. Karottki, M. Sander, T. Hørmann Thomsen, B. Biering-Sørensen (Glostrup, Denmark)

    Objective: This study evaluated the potential of wearables and AI-driven continuous monitoring to assess motor symptoms in Parkinson’s disease (PD). We aimed to determine their…
  • 2025 International Congress

    Hospitalization Safety in Parkinson’s Disease (PD): Baseline Outcomes Tracked over 1 Year and a Multi-disciplinary Program to Improve Care

    A. Carpentier, H. Martin, M. Musalo, I. Malaty (Montreal, Canada)

    Objective: To report baseline hospitalization outcomes in PD and the development of a comprehensive program for quality improvement. Background: Hospitalization is common in PD and…
  • 2025 International Congress

    Movement-Disorders Focused Clinical Neuroscience Training for Psychiatry Residents: A Competency-Based Medical Education Model

    A. Seritan (San Francisco, USA)

    Objective: To illustrate a novel educational program model that can train psychiatrists to develop competencies in caring for patients with movement disorders such as Parkinson's…
  • 2025 International Congress

    Patient engagement in Parkinson’s research: Exploring stakeholder perspectives

    J. Bek, N. Simonian, C. Rattan, A. Asis (Dublin, Ireland)

    Objective: The aim of this project was to explore patient engagement in Parkinson’s research in Canada from the perspectives of different stakeholders, and to identify…
  • 2025 International Congress

    Aquatic Interval Training in Individuals with Parkinson’s Disease: Can It Improve Gait?

    T. Christinelli, G. Leveck, L. Paladini, S. Souza, V. Israel (Curitiba, Brazil)

    Objective: To identify changes in gait speed and gait-related activities after an aquatic interval training physiotherapy program in individuals with PD. Background: Parkinson's disease (PD)…
  • 2025 International Congress

    Lewy Pathology in the Peripheral Nervous System of SNCA Duplication

    G. Beck, M. Yamadera, A. Tarutani, Y. Yonenobu, M. Hasegawa, S. Murayama, H. Mochizuki (Suita, Japan)

    Objective: This study aimed to investigate the degree, distribution, and biochemical profile of phosphorylated α-synuclein (p-α-syn) in the peripheral nervous system of patients with SNCA…
  • 2025 International Congress

    Wearable-based digital measures from the Verily Study Watch can detect concurrent symptomatic treatment effects in a subset of early-stage Parkinson’s disease ORCHESTRA trial participants

    B. Bloem, V. Hinson, L. Gaetano, E. Goikoetxea, K. Ray, F. Ambrosetti, V. Ticcinelli, M. Key Prato, A. Pethe, C. Serrano Amenos, J. Trzebinski, S. Warma, A. Khanna, Z. Ali (Nijmegen, Netherlands)

    Objective: To investigate the effect of concurrent symptomatic treatment (ST) on digital measures collected in ORCHESTRA (NCT04658186). Background: Minzasolmin is an oral small molecule that…
  • 2025 International Congress

    A Double-Blind, Cross-Over Pilot Study Comparing Adaptive Deep Brain Stimulation (aDBS) to Conventional DBS in Parkinson’s Disease

    T. Hashimoto, J. Tanimura, T. Yako (Matsumoto, Japan)

    Objective: To compare the efficacy of adaptive deep brain stimulation (aDBS) to conventional DBS (cDBS) in Parkinson’s disease through a double-blind, cross-over pilot study. Background:…
  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley